BioStem Technologies annual operating income
2021
2022
2023
2024
2025
BioStem Technologies Operating Income Growth & History (BSEM)
BioStem Technologies's operating income was −$689,147 for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$689,147 | −$31.8M | — |
| 2024 | 2024-12-31 | $31.1M | $38.9M | — |
| 2023 | 2023-12-31 | −$7.8M | −$3.1M | — |
| 2022 | 2022-12-31 | −$4.7M | −$3.1M | — |
| 2021 | 2021-12-31 | −$1.6M | — | — |
BioStem Technologies quarterly operating income
Q4.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$8.4M | −$8.5M | — |
| Q1 2026 | 2026-03-31 | −$8.1M | −$4.6M | — |
| Q3 2025 | 2025-09-30 | $1.4M | — | — |
| Q2 2025 | 2025-06-30 | $112,759 | — | — |
| Q1 2025 | 2025-03-31 | −$3.5M | — | — |
| Q4 2024 | 2024-12-31 | $8.5M | — | — |
BioStem Technologies operating income trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's operating income increased from −$1.6M to −$689,147, a change of $916,559. The latest reported quarter, Q2 2026, shows −$8.4M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗